These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21212009)

  • 1. Computational investigation of interactions between human H2 receptor and its agonists.
    Sun X; Li Y; Li W; Xu Z; Tang Y
    J Mol Graph Model; 2011 Feb; 29(5):693-701. PubMed ID: 21212009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modeling and antagonist binding site study of the human histamine H2 receptor.
    Zhang J; Qi T; Wei J
    Med Chem; 2012 Nov; 8(6):1084-92. PubMed ID: 22779803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chiral NG-acylated hetarylpropylguanidine-type histamine H2 receptor agonists do not show significant stereoselectivity.
    Ghorai P; Kraus A; Birnkammer T; Geyer R; Bernhardt G; Dove S; Seifert R; Elz S; Buschauer A
    Bioorg Med Chem Lett; 2010 May; 20(10):3173-6. PubMed ID: 20409707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The agonistic binding site at the histamine H2 receptor. II. Theoretical investigations of histamine binding to receptor models of the seven alpha-helical transmembrane domain.
    Nederkoorn PH; van Gelder EM; Donné-Op den Kelder GM; Timmerman H
    J Comput Aided Mol Des; 1996 Oct; 10(5):479-89. PubMed ID: 8951655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
    Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
    J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of histaprodifens at four recombinant histamine H1 receptor species isoforms.
    Strasser A; Striegl B; Wittmann HJ; Seifert R
    J Pharmacol Exp Ther; 2008 Jan; 324(1):60-71. PubMed ID: 17928567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.
    Jongejan A; Lim HD; Smits RA; de Esch IJ; Haaksma E; Leurs R
    J Chem Inf Model; 2008 Jul; 48(7):1455-63. PubMed ID: 18553960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):983-95. PubMed ID: 17332265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):253-64. PubMed ID: 17999052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors.
    Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for ligand-specific conformations of the histamine H(2)-receptor in human eosinophils and neutrophils.
    Reher TM; Brunskole I; Neumann D; Seifert R
    Biochem Pharmacol; 2012 Nov; 84(9):1174-85. PubMed ID: 22922404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational modeling toward understanding agonist binding on dopamine 3.
    Zhao Y; Lu X; Yang CY; Huang Z; Fu W; Hou T; Zhang J
    J Chem Inf Model; 2010 Sep; 50(9):1633-43. PubMed ID: 20695484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N(G)-acylated aminothiazolylpropylguanidines as potent and selective histamine H(2) receptor agonists.
    Kraus A; Ghorai P; Birnkammer T; Schnell D; Elz S; Seifert R; Dove S; Bernhardt G; Buschauer A
    ChemMedChem; 2009 Feb; 4(2):232-40. PubMed ID: 19072936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.